| Lot Release Number |
2020-12-09-0320
|
| FDA Registered Product/Generic Name |
Diphtheria, Tetanus, Pertussis (Acellular Component), Poliomyelitis (Inactivated) Vaccine and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed) [DTaP-IPV and HiB]
|
| Brand Name |
Pentaxim
|
| Dosage Strength |
Suspension and Powder for Suspension for Injection (IM)
|
| Dosage Form |
Suspension and Powder for Suspension for Injection
|
| Registration Number |
BR-523
|
| Batch/Lot Number |
U0A29
|
| Packaging Lot |
Packaging Lot: Box - U0A291V; Vial (Hib) - R3L55
[MD: 16102018; ED: 04-2021; PFS (DtaP-IPV) - R3N62
[MD: 31052018; ED: 04-2021; Needle (25G x 5/8") - 1909038
[ED: 2024-08-31]; Needle (23G x 1") - 1906027 [ED: 2024-05-31]
|
| Product Expiration Date |
Apr 2021
|
| Issuance Date |
11 December 2020
|